American Data Privacy and Protection Act American Data Privacy and Protection Act (ADPPA)

2022 was another year of high activity and significant developments in the realm of artificial intelligence (“AI”) and biometric privacy related matters, including in regard to issues arising under the Illinois Biometric Information Privacy Act (“BIPA”) and others.  This continues to be one of the most frequently litigated areas of privacy law, with several notable rulings and emerging patterns of new activity by the plaintiffs’ bar.  Following up on Privacy World’s Q2 and Q3 2022 Artificial Intelligence & Biometric Privacy Quarterly Newsletters, be sure to read on for a recap of key developments and insight as to where 2023 may be headed.

Continue Reading Privacy World 2022 Year in Review: Biometrics and AI

2022 was another eventful year in the realm of privacy, security and innovation.  Privacy World was there every step of the way, to keep you informed on key developments.  Starting next week, we will be rolling out our popular Year in Review series.  As a lead up to that, below are our ten most popular

In case you missed it, below are recent posts from Consumer Privacy World covering the latest developments on data privacy, security and innovation. Please reach out to the authors if you are interested in additional information.

Our Team Joined the Discussion on the Stage of the Global Data Protection Congress 2022 | Consumer Privacy World

CPW’s Kristin Bryan joins two of Squire Patton Boggs’ policy experts – Beth Goldstein and Jeffrey Turner – to discuss one of the most critical pieces of privacy legislation in years, the American Data Privacy and Protection Act (ADPPA), for Lexology’s Masterclass series. This game-changing privacy legislation not only has potential far-reaching impact, but

Today, the Federal Trade Commission (“Commission”) issued an advanced notice of public rulemaking on commercial surveillance, seeking public comment on whether new rules are needed to protect people’s privacy and information.  The notice, which is broad and sweeping, seeks comment on dozens of questions, categorized into the following topics:

  • Harms to Consumers
  • Harms to